Pharmena Statistics

Total Valuation

Pharmena has a market cap or net worth of PLN 34.30 million. The enterprise value is 34.13 million.

Market Cap	34.30M
Enterprise Value	34.13M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Pharmena has 11.14 million shares outstanding.

Current Share Class	11.14M
Shares Outstanding	11.14M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.86%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.93
PB Ratio	3.25
P/TBV Ratio	3.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-15.54
EV / Sales	26.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.97

Financial Position

The company has a current ratio of 13.52, with a Debt / Equity ratio of 0.02.

Current Ratio	13.52
Quick Ratio	1.19
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	-204.00

Financial Efficiency

Return on equity (ROE) is -19.70% and return on invested capital (ROIC) is -18.03%.

Return on Equity (ROE)	-19.70%
Return on Assets (ROA)	-17.02%
Return on Invested Capital (ROIC)	-18.03%
Return on Capital Employed (ROCE)	-30.58%
Revenue Per Employee	182,000
Profits Per Employee	-313,714
Employee Count	7
Asset Turnover	0.11
Inventory Turnover	0.30

Taxes

Income Tax	-468,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.64% in the last 52 weeks. The beta is 0.47, so Pharmena's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-31.64%
50-Day Moving Average	3.37
200-Day Moving Average	3.74
Relative Strength Index (RSI)	38.42
Average Volume (20 Days)	3,460

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmena had revenue of PLN 1.27 million and -2.20 million in losses. Loss per share was -0.20.

Revenue	1.27M
Gross Profit	1.08M
Operating Income	-3.26M
Pretax Income	-2.66M
Net Income	-2.20M
EBITDA	-3.22M
EBIT	-3.26M
Loss Per Share	-0.20

Full Income Statement

Balance Sheet

The company has 356,000 in cash and 184,000 in debt, giving a net cash position of 172,000 or 0.02 per share.

Cash & Cash Equivalents	356,000
Total Debt	184,000
Net Cash	172,000
Net Cash Per Share	0.02
Equity (Book Value)	10.54M
Book Value Per Share	0.95
Working Capital	9.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.63 million and capital expenditures -220,000, giving a free cash flow of -2.85 million.

Operating Cash Flow	-2.63M
Capital Expenditures	-220,000
Free Cash Flow	-2.85M
FCF Per Share	-0.26

Full Cash Flow Statement

Margins

Gross margin is 84.54%, with operating and profit margins of -256.20% and -172.37%.

Gross Margin	84.54%
Operating Margin	-256.20%
Pretax Margin	-209.11%
Profit Margin	-172.37%
EBITDA Margin	-252.83%
EBIT Margin	-256.20%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 27.60%.

Dividend Per Share	0.85
Dividend Yield	27.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	28.52%
Earnings Yield	-6.40%
FCF Yield	-8.31%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmena has an Altman Z-Score of 32.69 and a Piotroski F-Score of 2.

Altman Z-Score	32.69
Piotroski F-Score	2